ResMed Inc (RMD)
Cash conversion cycle
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 98.42 | 99.99 | 112.72 | 120.90 | 131.57 | 140.85 | 147.25 | 133.92 | 116.39 | 104.86 | 96.46 | 84.81 | 80.13 | 96.67 | 104.74 | 121.43 | 122.79 | 107.26 | 116.63 | 113.34 |
Days of sales outstanding (DSO) | days | 65.28 | 62.80 | 59.95 | 58.57 | 61.68 | 61.63 | 64.25 | 61.39 | 57.66 | 51.47 | 54.64 | 61.44 | 68.66 | 60.93 | 59.42 | 55.71 | 58.59 | 70.04 | 69.22 | 66.77 |
Number of days of payables | days | 28.46 | 21.39 | 24.45 | 22.34 | 19.88 | 22.55 | 29.18 | 28.10 | 24.92 | 23.62 | 26.61 | 29.08 | 24.20 | 23.41 | 26.95 | 29.87 | 39.99 | 34.73 | 35.29 | 34.84 |
Cash conversion cycle | days | 135.25 | 141.40 | 148.22 | 157.14 | 173.38 | 179.93 | 182.31 | 167.21 | 149.14 | 132.71 | 124.49 | 117.17 | 124.59 | 134.19 | 137.21 | 147.27 | 141.39 | 142.58 | 150.55 | 145.27 |
June 30, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 98.42 + 65.28 – 28.46
= 135.25
The cash conversion cycle of ResMed Inc has exhibited fluctuations over the past few quarters. The company's cash conversion cycle, which represents the time it takes for a company to convert its investments in inventory and other resources into cash flows from sales, has ranged from a low of 117.17 days to a high of 182.31 days over the last few years.
On average, the cash conversion cycle for ResMed Inc has been around 150 days, indicating that the company takes approximately five months to convert its investment in inventory into cash sales. A higher cash conversion cycle indicates that the company takes longer to sell its inventory and collect cash from customers, which could potentially signal inefficiencies in the company's operations or challenges in managing working capital.
It is important for ResMed Inc to monitor and manage its cash conversion cycle effectively to optimize its working capital management and ensure efficient use of resources. By reducing the cash conversion cycle, the company can improve its cash flow, liquidity, and overall financial performance.
Peer comparison
Jun 30, 2024